Platelets Retain High Levels of Active Plasminogen Activator Inhibitor 1
Open Access
- 1 November 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (11), e26762
- https://doi.org/10.1371/journal.pone.0026762
Abstract
The vascular fibrinolytic system is crucial for spontaneous lysis of blood clots. Plasminogen activator inhibitor 1 (PAI-1), the principal inhibitor of the key fibrinolytic enzyme tissue-type plasminogen activator (tPA), is present in platelets at high concentrations. However, the majority of PAI-1 stored in platelets has been considered to be inactive. Our recent finding (Brogren H, et al. Blood 2004) that PAI-1 de novo synthesized in platelets remained active for over 24 h, suggested that PAI-1 stored in the α-granules might be active to a larger extent than previously reported. To re-evaluate this issue, we performed experiments where the fraction of active PAI-1 was estimated by analyzing the tPA-PAI-1 complex formation. In these experiments platelets were lysed with Triton X-100 in the presence of serial dilutions of tPA and subsequently the tPA-PAI-1 complex was evaluated by Western blot. Also, using a non-immunologic assay, tPA was labeled with 125I, and 125I-tPA and 125I-tPA-PAI-1 was quantified by scintigraphy. Interestingly, both methods demonstrated that the majority (>50%) of platelet PAI-1 is active. Further analyses suggested that pre-analytical procedures used in previous studies (sonication or freezing/thawing) may have substantially reduced the activity of platelet PAI-1, which has lead to an underestimation of the proportion of active PAI-1. Our in vitro results are more compatible with the role of PAI-1 in clot stabilization as demonstrated in physiological and pathophysiological studies.Keywords
This publication has 46 references indexed in Scilit:
- Platelets synthesize large amounts of active plasminogen activator inhibitor 1Blood, 2004
- High Concentrations of Active Plasminogen Activator Inhibitor-1 in Porcine Coronary Artery ThrombiArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Calcium-dependent Stabilization of Type I Plasminogen Activator Inhibitor within Plateletα-GranulesPublished by Elsevier BV ,1996
- Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasmaFEBS Letters, 1988
- Plasminogen activator inhibitor (PAI‐1) in plasma and plateletsBritish Journal of Haematology, 1988
- Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.JCI Insight, 1984
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970